AFFYMAX INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2009-12-10: Form 8-K; Period of report 2009-12-08; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Details 1.01.
- 2009-11-20: Form 8-K; Period of report 2009-11-19; Description 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events; Details 1.01.
- 2009-11-05: Form 8-K; Period of report 2009-11-04; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2009-11-03: Form 8-K; Period of report 2009-10-29; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2009-12-10 | 8-K | 2009-12-08 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 The information set forth in Item 1.01 above is incorporated by reference herein. | a09-35187_18k.htm |
| 2009-11-20 | 8-K | 2009-11-19 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 Attached as Exhibit 5.1 to this Current Report on Form 8-K is the opinion of Cooley Godward Kronish LLP relating to the validity of the Shares to be issued in the offering. | a09-29175_88k.htm |
| 2009-11-05 | 8-K | 2009-11-04 | 2.02 Results of Operations and Financial Condition | 2.02 On November 4, 2009, Affymax, Inc. issued a press release announcing its financial results for the quarterly period ended September 30, 2009. | a09-32951_18k.htm |
| 2009-11-03 | 8-K | 2009-10-29 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (b) On October 29th, 2009, Dr. Nicholas Galakatos, currently lead director of Affymax, Inc. (the “Company”) and Chairman of the Nominating and Governance Committee, informed the Company that he would resign as a director of the Company effective as of December 31, 2009. | a09-32649_18k.htm |
| 2009-09-25 | 8-K | 2009-09-25 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | a09-25780_28k.htm |
| 2009-09-09 | 8-K | 2009-09-08 | 8.01 Other Events | 8.01 On September 8, 2009, Affymax, Inc. (the “Company”) notified clinical trial sites to complete treatment of patients in the Phase 3 clinical program for the investigational drug, Hematide™, by the end of 2009. | a09-25780_18k.htm |
| 2009-08-06 | 8-K | 2009-08-05 | 2.02 Results of Operations and Financial Condition | 2.02 On August 5, 2009, Affymax, Inc. issued a press release announcing its financial results for the quarterly period ended June 30, 2009. | a09-21345_18k.htm |
| 2009-06-11 | 8-K | 2009-06-09 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On June 9, 2009, the Board of Directors of Affymax, Inc. (the “Company”) appointed Mr. Hollings C. Renton as a director to serve until his successor is duly elected and qualified at the Company’s annual meeting of stockholders to be held in 2011. | a09-15588_18k.htm |
| 2009-05-07 | 8-K | 2009-05-07 | 2.02 Results of Operations and Financial Condition | 2.02 On May 7, 2009, Affymax, Inc. issued a press release announcing its financial results for the quarterly period ended March 31, 2009. | a09-12858_18k.htm |
| 2009-03-16 | 8-K | 2009-03-12 | 2.02 Results of Operations and Financial Condition | 2.02 On March 12, 2009, Affymax, Inc. issued a press release announcing its financial results for the year ended December 31, 2008. | a09-7779_18k.htm |
| 2009-02-19 | 8-K | 2009-02-13 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 3.02 The information set forth in Item 1.01 of this Current Report on Form 8-K that relates to agreements to sell unregistered equity securities of Affymax in a private placement is incorporated herein by reference. 8.01 On February 17, 2009, Affymax issued a press release titled “Affymax Announces $42 Million Private Placement.” A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. | a09-5856_18k.htm |
| 2009-01-20 | 8-K | 2009-01-15 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 * The shares vest and become exercisable in a series of forty-eight (48) successive equal monthly installments over the four (4) year period measured from January 1, 2009. | a09-3355_18k.htm |